Trademark: 97201801
Status Date
Tuesday, September 12, 2023
Registration Number
7160338
Registration Date
Tuesday, September 12, 2023
Filing Date
Tuesday, January 4, 2022
Published for Opposition
Tuesday, June 27, 2023
5 Anti-diabetic pharmaceuticals; Biological preparations for the treatment of endocrine related diseases and disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for endocrine related diseases and disorders; Insulin; Medicinal herbal preparations; Medicinal preparations for metabolic system related diseases and disorders; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical preparations for the treatment of Diabetes; Syringes sold filled with insulin; Syringes sold filled with anti-diabetic pharmaceuticals
The wording "Blasilin" has no meaning in a foreign language.
Sep 12, 2023
Notice Of Registration Confirmation Emailed
Sep 12, 2023
Registered-Principal Register
Jun 27, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 27, 2023
Published For Opposition
Jun 7, 2023
Notification Of Notice Of Publication E-Mailed
May 23, 2023
Electronic Record Review Complete
May 19, 2023
On Hold - Electronic Record Review Required
May 15, 2023
Approved For Pub - Principal Register
Apr 27, 2023
Notification Of Inquiry As To Suspension E-Mailed
Apr 27, 2023
Inquiry To Suspension E-Mailed
Apr 27, 2023
Suspension Inquiry Written
Apr 20, 2023
Suspension Checked ¿ To Attorney For Action
Feb 13, 2023
Teas Response To Suspension Inquiry Received
Oct 13, 2022
Notification Of Letter Of Suspension E-Mailed
Oct 13, 2022
Letter Of Suspension E-Mailed
Oct 13, 2022
Suspension Letter Written
Oct 10, 2022
Assigned To Examiner
Jan 7, 2022
New Application Office Supplied Data Entered
Jan 7, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
